ThinkEquity Starts Par Pharmaceutical (PRX) at Buy
Tweet
Share
E-mailGet Alerts PRX Hot Sheet
Price: $49.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Join SI Premium – FREE
ThinkEquity initiates coverage on Par Pharmaceutical (NYSE: PRX) with a Buy. PT $35.00.
For more ratings news on Par Pharmaceutical click here and for the rating history of Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $27.87 yesterday.
For more ratings news on Par Pharmaceutical click here and for the rating history of Par Pharmaceutical click here.
Shares of Par Pharmaceutical closed at $27.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BWS Financial Starts Twist Bioscience (TWST) at Sell, 'Insider selling activity picked up steam'
- Nomura/Instinet Starts Keboda Technology (603786:CH) at Buy
- JPMorgan Starts SK Hynix (SKHY) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
